Company Monitoring Page for Biogen

latest headlines for company on cafepharma

Sangamo Therapeutics and Biogen Announce Gene-Therapy Deal, Stock up 39%
Motley Fool
Thu, 02/27/20 - 11:43 pm
Tags:
Sangamo Therapeutics, Biogen, gene therapy, gene editing, Parkinson's Disease, Alzheimer's disease
Pharmacquired: Where are all the deals?
BioPharma Dive
Thu, 02/27/20 - 10:46 am
Tags:
M&A, Gilead Sciences, Biogen, Sanofi, Eli Lilly, GSK, Merck, Vertex Pharmaceuticals
Will Biogen’s Big Patent Victory Ease Investor Worries About Its Alzheimer’s Drug?
Motley Fool
Tue, 02/11/20 - 10:36 am
Tags:
Biogen, Mylan, Alzheimer's disease, patents, Tecfidera, MS, multiple sclerosis, Vumerity
Multiple Sclerosis Update: Biogen, Sanofi, Active, Adamas and Novartis
BioSpace
Sun, 02/9/20 - 04:01 pm
Tags:
MS, multiple sclerosis, Biogen, Sanofi, Active Biotech, Mylan, Novartis, Adamas
Biogen wins Tecfidera patent challenge from Mylan, sending shares way up
Fierce Pharma
Wed, 02/5/20 - 10:25 pm
Tags:
Biogen, patents, Tecfidera, Mylan, multiple sclerosis, MS
Biogen Profits Up in 2019 Despite Aducanumab Drama
BioSpace
Thu, 01/30/20 - 09:24 pm
Tags:
Biogen, earnings, aducanumab
5 biopharmas to watch as the decade's last earnings kick off
BioPharma Dive
Wed, 01/22/20 - 11:06 am
Tags:
earnings, Novartis, Biogen, Eli Lilly, Global Blood Therapeutics, Bluebird Bio
2 Reasons to be Optimistic About Biogen’s Alzheimer’s Drug
Motley Fool
Tue, 01/21/20 - 11:35 pm
Tags:
Biogen, Alzheimer's disease, aducanumab
Who are the 10 Most Innovative Biopharma Companies?
BioSpace
Fri, 01/17/20 - 11:41 pm
Tags:
innovation, Regeneron, Verily, Illumina, Biogen, Bayer, Bluebird Bio, Novartis, GSK, Genentech, Amgen
Analysts tip Biogen to file for aducanumab approval within weeks
Fierce Biotech
Thu, 01/16/20 - 10:10 am
Tags:
Biogen, Alzheimer's disease, aducanumab, FDA
JPM: Already prepping for Alzheimer's launch, Biogen scouts 'top talent' and talks pricing
Fierce Pharma
Tue, 01/14/20 - 10:49 am
Tags:
Biogen, Alzheimer's disease, drug pricing, aducanumab, JPMHC 2020
Roche aims to 'underwhelm' with risdiplam price as it enters SMA rivalry with Biogen, Novartis — report
Endpoints
Tue, 01/14/20 - 10:20 am
Tags:
SMA, Roche, risdiplam, Biogen, Novartis, drug pricing
New MS Trial Will be First to Compare Stem Cell Therapy with Best Available Biologics
Xtalks
Mon, 01/13/20 - 11:35 pm
Tags:
stem cells, MS, multiple sclerosis, NIH, AHSCT, Biogen, Tysabri, Sanofi, Lemtrada, Roche, Ocrevus, Rituxan
Biogen makes another Alzheimer's bet, paying Pfizer $75M for early-phase drug
Fierce Biotech
Mon, 01/13/20 - 10:51 am
Tags:
Biogen, Alzheimer's disease, Pfizer, PF-05251749
A Preview Of JPMorgan's Healthcare Conference: Focus On Value-Creating Themes, 2020 Expectations
Yahoo/Benzinga
Sat, 01/11/20 - 11:02 pm
Tags:
JPMHC 2020, Bristol-Myers Squibb, Vertex Pharmaceuticals, Biomarin, Regeneron, Biogen, Alexion, Gilead Sciences, Amgen
Biogen Teams Up With Startup CAMP4 to Scout for New Neuro Drugs
Xconomy
Fri, 01/10/20 - 10:18 am
Tags:
Biogen, Neuroscience, CAMP4 Therapeutics, drug development
Biogen and the desperation of a need for Alzheimer's drugs
Fierce Biotech
Fri, 12/20/19 - 08:13 pm
Tags:
Biogen, FDA, Alzheimer's disease, aducanumab
After Recent Tau Failure, Biogen Licenses Tau Therapeutic from Ionis for Alzheimer's Disease
BioSpace
Thu, 12/19/19 - 01:04 pm
Tags:
Biogen, Alzheimer's disease, IONIS-MAPTRx, Ionis Pharmaceuticals
Biogen chalks up another failure, but investors' eyes remain firmly on Alzheimer's
Fierce Biotech
Fri, 12/13/19 - 12:26 pm
Tags:
Biogen, Alzheimer's disease, aducanumab, progressive supranuclear palsy, gosuranemab, clinical trials
Biogen Points to Enrollment and Dosing to Explain Alzheimer’s Results
Xconomy
Thu, 12/5/19 - 11:35 pm
Tags:
Biogen, Alzheimer's disease, aducanumab, Worldwide Clinical Trials

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.